AJR ARRS Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergey, P. D.
Right arrow Articles by Axel, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergey, P. D.
Right arrow Articles by Axel, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2000; 174:242-244
© American Roentgen Ray Society


Technical Innovation

Focal Hypertrophic Cardiomyopathy Simulating a Mass

MR Tagging for Correct Diagnosis

Philip D. Bergey1 and Leon Axel1

1 Both authors: Department of Radiology, University of Pennsylvania Medical Center, 3400 Spruce St., Philadelphia PA 19104-6100

Received November 9, 1998; accepted after revision May 10, 1999.

 
Supported in part by National Institutes of Health grant RR02305.

Address correspondence to P.D. Bergey.


Introduction
Top
Introduction
Materials and Methods
Results
Discussion
References
 
MR tagging refers to an ensemble of techniques that noninvasively and magnetically label tissue elements so their positions can be tracked as a function of time with MR imaging. One such tagging technique—spatial modulation of magnetization—is useful for the qualitative and quantitative evaluation of heart wall motion [1, 2, 3, 4, 5, 6, 7].

A common problem in cardiac MR imaging is the evaluation of a suspected space-occupying mass in the wall of the heart. Bouton et al. [8] showed that MR tagging helps to define the edges of a space-occupying cardiac mass because of the absence of active contraction in the mass. This report makes the converse point: namely, that when cardiac hypertrophy is localized and masslike, MR tagging confirms the presence of contractile function in the suspected mass, thus helping to make the correct diagnosis. This hypothesis is consistent with previous work [4, 5] that showed that hypertrophic cardiomyopathy is characterized by reduced myocardial segment shortening compared with that of healthy myocardium.


Materials and Methods
Top
Introduction
Materials and Methods
Results
Discussion
References
 
Image Acquisition
Cardiac MR imaging was performed on a conventional 1.5-T MR imaging system (Signa; General Electric Medical Systems, Milwaukee, WI) using spatial modulation of magnetization pulse sequences developed in house. For the first patient we examined, an ECG-gated spin-echo sequence was used (data matrix, 256 x 128; slice thickness, 5 mm; TR, equal to the R-R interval; TE, 20 msec; two signals averaged) [2]. For the second patient we examined, an ECG-gated segmented K-space, low flip angle gradient-echo sequence with two-dimensional spatial modulation of magnetization tagging pulses was used (data matrix, 256 x 128; slice thickness, 8 mm; TR/TE, 6.5/2.6; flip angle, 20°; no signal averaging; eight views per segment) [7]. In both examinations, tagging pulses were applied once per cardiac cycle, a few milliseconds after the R wave of the ECG. Tagged images were captured at several trigger delays throughout systole, so that tag displacement and deformation indicated systolic contractile function in the myocardium.

Patient Studies
The first patient we studied was a 51-year-old healthy woman who underwent ECG and echocardiography because of a cardiac murmur; she had no other complaints. ECG revealed a left axis and precordial Q waves, raising the question of prior myocardial infarction. Echocardiography showed a possible cardiac mass, and MR imaging was performed for further evaluation.

The second patient was a 27-year-old man with dizziness and a cardiac murmur in whom both transthoracic and transesophageal echocardiograms were consistent with hypertrophic cardiomyopathy. Both echocardiograms showed a 2-cm discrete pedunculated portion of the interventricular septum bulging in the right ventricular outflow tract. We thought that this was consistent with a variant of hypertrophic cardiomyopathy, but a cardiac neoplasm could not be excluded. MR imaging was performed to obtain greater specificity.


Results
Top
Introduction
Materials and Methods
Results
Discussion
References
 
ECG-gated spin-echo images of the first patient in the short-axis plane of orientation (Fig. 1A) showed localized masslike thickening of the left ventricular free wall, which was isointense to the rest of the myocardium. Gadolinium contrast agent enhancement of the focally thickened region was similar, but not identical, to that of adjacent myocardium. ECG-gated spin-echo images with two-dimensional spatial modulation of magnetization (Fig. 1B) showed that throughout systole, tag displacement and deformation occurred both in the region of localized thickening and in the adjacent, more healthy myocardium. Moreover, tag deformation varied smoothly across the observed myocardium, with no obvious interface or discontinuity. In both the region of focal thickening and the adjacent healthy wall, there was circumferential shortening and radial elongation during systole, although the amount of regional contraction was relatively reduced in the focally thickened area. Clinical suspicion of neoplasm persisted, and the patient had an open biopsy 10 weeks after MR imaging. The final microscopic diagnosis was hypertrophied myocardial fibers with interdigitating fibrosis and no evidence of neoplasm. The patient did well after surgery and had follow-up MR imaging 6 months later, approximately 38 weeks after the first MR imaging was performed; findings were unchanged at that time.



View larger version (109K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1 .—51-year-old asymptomatic woman.

A, Short-axis MR image shows localized hypertrophy in left ventricular free wall, simulating mass. Imaging was performed using ECG-gated spin-echo sequence (data matrix, 256 x 128; slice thickness, 5 mm; TR/TE, 600/20; two signals averaged; trigger delay, 188 msec after R wave).

 


View larger version (52K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1 .—51-year-old asymptomatic woman.

B, Short-axis tagged MR images obtained at five successive trigger delays show active displacement and deformation of tags in region of localized hypertrophy. Imaging was performed using ECG-gated, spin-echo sequence (data matrix, 256 x 128; slice thickness, 5 mm, TR/TE, 632/20; two signals averaged). Trigger delays are indicated in msec.

 

ECG-gated spin-echo images of the second patient, in the transverse plane (Fig. 2A), showed generalized hypertrophy with marked localized thickening of the interventricular septum, which was bulging in the right ventricular outflow tract. ECG-gated segmented gradientecho images with two-dimensional spatial modulation of magnetization, in the long-axis plane transverse to the septum (Fig. 2B), showed active contractile function in the region of septal thickening. The MR imaging diagnosis was hypertrophic cardiomyopathy with evidence of right ventricular outflow obstruction. In this patient, the correct diagnosis became apparent in two ways. First, tagged images revealed that all parts of the septum contracted actively, excluding a space-occupying mass. Second, we were able to exclude a tumor on morphologic grounds by moving from the transverse image plane (Fig. 2A), in which a lobulated portion of hypertrophied septum was seen bulging in the right ventricle, to the oblique long-axis plane transverse to the septum (Fig. 2B), in which the septum had a configuration typical of hypertrophic cardiomyopathy. The patient did well with conventional treatment of his condition and was followed for more than 2 years after the MR imaging study without clinical deterioration.



View larger version (107K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2 .—27-year-old man with hypertrophic cardiomyopathy.

A, Transverse MR image shows localized hypertrophy in interventricular septum, simulating mass. Imaging was performed using ECG-gated spin-echo sequence (data matrix, 256 x 128; slice thickness, 5 mm; TR/TE, 952/11; two signals averaged; trigger delay, 231 msec after R wave). This image plane shows lobulated pseudomass bulging into right ventricle. Best practice is to acquire tagged images in same plane, which preserves worrisome morphology and shows contraction within morphology via tags. Altering image plane (as in B) may show septal thickening in characteristic configuration that dispels concern about mass, facilitating correct diagnosis. Ideally, two strategies complement one another.

 


View larger version (51K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2 .—27-year-old man with hypertrophic cardiomyopathy.

B, Long-axis tagged MR images obtained at five successive trigger delays show active displacement and deformation of tags in region of localized hypertrophy. Imaging was performed using ECG-gated segmented K-space, low flip angle gradient-echo sequence (data matrix, 256 x 128; slice thickness, 8 mm; TR/TE, 6.5/2.6; flip angle, 20°; no signal averaging; eight views per segment). Trigger delays are indicated in msec. Moving from transverse plane (A) to oblique long-axis plane transverse to septum (B) alters configuration of septal hypertrophy, which now appears less masslike. It is probably better to acquire tagged MR images in exact plane that shows worrisome pseudomass, which facilitates showing that questionable tissue is contractile.

 


Discussion
Top
Introduction
Materials and Methods
Results
Discussion
References
 
When using MR imaging to evaluate a possible space-occupying mass, morphology and signal intensity are often consistent, but on occasion they may seem to conflict. In both of our patients, localized regions of hypertrophic myocardium simulated space-occupying masses, but these regions were approximately isointense to adjacent myocardium, and there was no other sharp demarcation in regional MR imaging appearance between mass and uninvolved heart muscle. Contractile function, as revealed with MR tagging, is an additional property that can be used to characterize the questionable tissue as either functionally similar to or different from adjacent myocardial segments. When Bouton et al. [8] exploited this principle to characterize a rhabdomyoma by its lack of contractile function, they implicitly accepted the idea that actively contracting tissue is nonneoplastic. To our knowledge, the converse point has never been documented in the literature. MR tagging is a useful adjunct in the clinical imaging of suspected cardiac masses, and it can be used to help either exclude or establish the presence of neoplasm. Further work is needed to define the sensitivity and specificity of the tagging technique and to expose its possible pitfalls. In theory, infiltrative conditions affecting the myocardium present a particular challenge. Hypertrophic cardiomyopathy is, in a sense, such a condition, because the pathologic finding of interstitial fibrosis is described [9]. Other forms of infiltrative cardiomyopathy, such as sarcoid or amyloid, or even some cases of ischemic cardiomyopathy, may masquerade as space-occupying tumors on tagged MR images if the contraction of residual myocardial tissue is inapparent. Perhaps more serious, infiltrating lymphoma or metastatic tumor may be misdiagnosed if the infiltrated myocardium contracts enough to simulate one of the benign infiltrative cardiomyopathies. These questions emphasize the preliminary nature of our work and the need for further study.


References
Top
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Axel L, Dougherty L. MR imaging of motion with spatial modulation of magnetization. Radiology 1989;171:841-845[Abstract/Free Full Text]
  2. Axel L, Dougherty L. Heart wall motion: improved method of spatial modulation of magnetization for MR imaging. Radiology 1989;172:349-350[Abstract/Free Full Text]
  3. Clark NR, Reichek N, Bergey P, et al. Circumferential myocardial shortening in the normal human left ventricle: assessment by magnetic resonance imaging using spatial modulation of magnetization. Circulation 1991;84:67-74[Abstract/Free Full Text]
  4. Kramer CM, Reichek N, Ferrari VA, Theobold T, Dawson J, Axel L. Regional heterogeneity of function in hypertrophic cardiomyopathy. Circulation 1994;90:186-194[Abstract/Free Full Text]
  5. Young AA, Kramer CM, Ferrari VA, Axel L, Reichek N. Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy. Circulation 1994;90:854-867[Abstract/Free Full Text]
  6. Young AA, Imai H, Chang CN, Axel L. Two-dimensional left ventricular deformation during systole using magnetic resonance imaging with spatial modulation of magnetization. Circulation 1994;89:740-752[Abstract/Free Full Text]
  7. Fayad ZA, Ferrari VA, Kraitchman DL, et al. Right ventricular regional function using MR tagging: normals versus chronic pulmonary hypertension. Magn Reson Med 1998;39:116-123[Medline]
  8. Bouton S, Yang A, McCrindle BW, Kidd L, McVeigh ER, Zerhouni EA. Differentiation of tumor from viable myocardium using cardiac tagging with MR imaging. J Comput Assist Tomogr 1991;15:676-678[Medline]
  9. Anderson KR, Sutton MG, Lie JT. Histopathological types of cardiac fibrosis in myocardial disease. J Pathol 1979;128:79-85[Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
M. W. Hansen and N. Merchant
MRI of Hypertrophic Cardiomyopathy: Part I, MRI Appearances
Am. J. Roentgenol., December 1, 2007; 189(6): 1335 - 1343.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergey, P. D.
Right arrow Articles by Axel, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergey, P. D.
Right arrow Articles by Axel, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS